Epilepsy is a common neurological disorder resulting from an imbalance between neuronal excitation and inhibition. Synapses play a pivotal role in the pathogenesis of epilepsy. Src-homology 2 (SH2) domain–containing protein 5 (SH2D5) is highly expressed in the brain and is implicated in the regulation of synaptic function. However, its role and mechanism in epilepsy remain unclear. In this study, we found that SH2D5 was predominantly localized to pyramidal neurons in the mouse hippocampus and was upregulated in the hippocampus of epileptic brains. KO of Sh2d5 in the hippocampus alleviated both the susceptibility to and severity of epileptic activity. Mechanistically, SH2D5 regulated N-methyl-D-aspartate receptor–mediated (NMDAR–mediated) excitatory synaptic transmission by altering the protein expression levels of NMDAR subunits. We further demonstrated that SH2D5 modulated the transcription of NMDARs by promoting the autophagic degradation of STAT1. These findings suggest that targeting the SH2D5/STAT1/NMDAR pathway may offer a potential therapeutic strategy for epilepsy.
This study provides a comprehensive assessment of the global burden of childhood epilepsy attributable to neonatal disorders, using data from the Global Burden of Disease Study 2021. From 1990 to 2021, the age-standardized prevalence rate and number of years lived with disability increased globally, with higher burdens observed among boys and in regions with lower Sociodemographic Index levels. Preterm birth was identified as the most significant neonatal cause of childhood epilepsy. These findings depict the burden of epilepsy attributable to neonatal disorders in children and underscore the need for targeted perinatal care strategies, particularly in low-resource settings, to reduce the long-term neurological sequelae in children worldwide.